v3.25.4
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

(5) FAIR VALUE MEASUREMENTS

ASC 820 establishes a hierarchical disclosure framework which ranks the observability of inputs used in measuring financial instruments at fair value. The observability of inputs is impacted by a number of factors, including the type of financial instruments and their specific characteristics. Financial instruments with readily available quoted prices, or for which fair value can be measured from quoted prices in active markets, generally will have a higher degree of market price observability and a lesser degree of judgment applied in determining fair value.

The three-level hierarchy for fair value measurements is defined as follows:

Level 1—inputs to the valuation methodology are quoted prices available in active markets for identical financial instruments as of the measurement date. The types of financial instruments in this category include unrestricted securities, including equities and derivatives, listed in active markets. The Company will not adjust the quoted price for these instruments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price.

Level 2—inputs to the valuation methodology are quoted prices in markets that are not active or for which all significant inputs are either directly or indirectly observable as of the measurement date. The types of financial instruments in this category include less liquid and restricted securities listed in active markets, securities traded in markets that are not active, and certain over-the-counter derivatives where the fair value is based on observable inputs.

Level 3—inputs to the valuation methodology are unobservable and significant to the overall fair value measurement and include situations where there is little, if any, market activity for the investment. The inputs into the determination of fair value require significant management judgment or estimation. The types of financial instruments in this category include investments in privately held entities, first and second lien debt, non-investment grade residual interests in securitizations and certain over-the-counter derivatives where the fair value is based on unobservable inputs.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the determination of which category within the fair value hierarchy is appropriate for any given financial instrument is based on the lowest level of input that is significant to the fair value measurement. Assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument.

Pursuant to the framework set forth above, the Company values securities traded in active markets on the measurement date by multiplying the exchange closing price of such traded securities/instruments by the quantity of shares or amount of the instrument held. The Company may also obtain quotes with respect to certain investments from pricing services, brokers or dealers’ quotes, or counterparty marks in order to value liquid assets that are not traded in active markets. Pricing services aggregate, evaluate and report pricing from a variety of sources including observed trades of identical or similar securities, broker or dealer quotes, model-based valuations and internal fundamental analysis and research. When doing so, the Company determines whether the quote obtained is sufficient according to U.S. GAAP to determine the fair value of the security. If determined adequate, the Company uses the quote obtained.

The valuation of investments which are illiquid or for which the pricing source, agent, service, and/or broker (as applicable) does not provide a valuation or methodology or provides a valuation or methodology that, in the judgment of the Valuation Designee or the Board, does not represent fair value, will each be valued as determined in good faith by the Valuation Designee, based on, among other things, the input of the Valuation Firms (as defined below). As part of the valuation process, the Valuation Designee takes into account relevant factors and appropriate techniques in determining the fair value of the Company’s investments, with the assistance of the independent valuation firms (“Valuation Firms”). The valuation techniques may vary by investment but include comparable public market valuations, comparable precedent transaction valuations and the discounted cash flow analyses. Non-controlled debt investments are generally fair valued using the discounted cash flow technique. Expected cash flows are projected based on contractual terms and discounted back to the measurement date based on a discount rate. Discount rate is determined based upon an assessment of current and expected yields for similar investments and risk profiles. Non-controlled equity investments are generally fair valued using a market approach and/or an income approach. The market approach typically utilizes market value multiples of comparable publicly traded companies. The income approach typically utilizes a discounted cash flow analysis of the portfolio company. The Valuation Designee, under the supervision of the Board of Directors undertakes a multi-step valuation process each quarter, as described below:

With respect to each portfolio company or investment for which market quotations are readily available, those investments will typically be valued at the average bid price of those market quotations;
With respect to each portfolio company or investment for which market quotations are not readily available, the Valuation Designee will engage one or more Valuation Firms to provide a preliminary independent valuations of the investments to the Valuation Designee. The Valuation Firms independently value such investments using quantitative and qualitative information according to the valuation methodologies in the Investment Adviser’s valuation policy;
The Valuation Designee reviews the recommended valuations and determines the fair value of each investment;
The Valuation Designee provides to the valuation committee, which is comprised of members of the Investment Adviser’s senior management, its valuation recommendation along with valuation-related information for each portfolio company or investment;
Each quarter, the Company’s audit committee (the “Audit Committee”) reviews the valuation assessments provided by the Valuation Designee and provides the Board with a report of the results of such review; and
The Board and Audit Committee each oversee the Valuation Designee and the valuation process.

Investment performance data utilized will be the most recently available as of the measurement date, which in many cases may reflect up to a one quarter lag in information.

The Board of Directors is ultimately responsible for the determination, in good faith, of the fair value of the Company’s portfolio investments.

The following tables present the fair value hierarchy of the investments as of:

 

 

 

December 31, 2025

 

December 31, 2024

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

Level 1

 

Level 2

 

Level 3

 

Total

First Lien Debt

$

$

530,125

$

5,894,570

$

6,424,695

$

$

555,530

$

5,442,166

$

5,997,696

Second Lien Debt

 

 

15,887

 

16,136

 

32,023

 

 

14,659

 

2,112

 

16,771

Other Debt Investments

 

 

 

11,564

 

11,564

 

 

 

6,520

 

6,520

Equity

 

 

2,037

 

55,015

 

57,052

 

 

2,037

 

55,995

 

58,032

Total Investments

$

$

548,049

$

5,977,285

$

6,525,334

$

$

572,226

$

5,506,793

$

6,079,019

Investment measured at net asset value (1)

 

 

 

 

 

 

$

85,276

 

 

 

 

 

 

$

Total Investments

 

 

 

 

 

 

$

6,610,610

 

 

 

 

 

 

$

6,079,019

Cash and cash equivalents

$

199,865

$

$

$

199,865

$

159,788

$

$

$

159,788

Unaffiliated money market

$

38,403

$

$

$

38,403

$

58,216

$

$

$

58,216

 

(1)
The Company, as a practical expedient, estimates the fair value of its investment in North Haven Keystone, LLC using the net asset value of the Company’s members’ interest in the entity. As such, the fair value has not been classified within the fair value hierarchy.

The following table presents changes in the fair value of the investments for which Level 3 inputs were used to determine the fair value for the years ended December 31, 2025:

 

 

 

First Lien
Debt

 

 

Second Lien
Debt

 

 

Other Debt
Investments

 

 

Equity

 

 

Total
Investments

 

Fair value, beginning of period

 

$

5,442,166

 

 

$

2,112

 

 

$

6,520

 

 

$

55,995

 

 

$

5,506,793

 

Purchases of investments(1)

 

 

1,658,225

 

 

 

13,407

 

 

 

4,468

 

 

 

7,584

 

 

 

1,683,684

 

Proceeds from principal repayments and sales of investments(1)

 

 

(1,188,702

)

 

 

 

 

 

 

 

 

(9,722

)

 

 

(1,198,424

)

Accretion of discount/amortization of premium

 

 

23,843

 

 

 

1

 

 

 

98

 

 

 

 

 

 

23,942

 

Payment-in-kind

 

 

18,633

 

 

 

616

 

 

 

990

 

 

 

5,425

 

 

 

25,664

 

Net change in unrealized appreciation (depreciation)

 

 

(48,017

)

 

 

 

 

 

(512

)

 

 

(7,540

)

 

 

(56,069

)

Net realized gains (losses)

 

 

(13,647

)

 

 

 

 

 

 

 

 

3,273

 

 

 

(10,374

)

Transfers into/out of Level 3 (3)

 

 

2,069

 

 

 

 

 

 

 

 

 

 

 

 

2,069

 

Fair value, end of period

 

$

5,894,570

 

 

$

16,136

 

 

$

11,564

 

 

$

55,015

 

 

$

5,977,285

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in unrealized appreciation (depreciation) from investments still held as of December 31, 2025

 

$

(44,758

)

 

$

 

 

$

(512

)

 

$

(7,448

)

 

$

(52,718

)

 

(1)
Purchases may include investments received in corporate action and restructurings.
(2)
Sales may include investments received in corporate action and restructurings.
(3)
Transfer of portfolio investments within the three-level hierarchy is recorded during the period of such reclassification occurrence at the fair value as of the beginning of the respective period. Generally, reclassifications are primarily due to increase/decrease of price transparency.

The following table presents changes in the fair value of the investments for which Level 3 inputs were used to determine the fair value for the years ended December 31, 2024:

 

 

 

First Lien
Debt

 

 

Second Lien
Debt

 

 

Other Debt
Investments

 

 

Equity

 

 

Total
Investments

 

Fair value, beginning of period

 

$

2,710,858

 

 

$

21,708

 

 

$

2,484

 

 

$

33,352

 

 

$

2,768,402

 

Purchases of investments(1)

 

 

3,384,782

 

 

 

2,406

 

 

 

3,537

 

 

 

17,351

 

 

 

3,408,076

 

Proceeds from principal repayments and sales of investments(2)

 

 

(659,416

)

 

 

(17,500

)

 

 

 

 

 

(173

)

 

 

(677,089

)

Accretion of discount/amortization of premium

 

 

18,946

 

 

 

393

 

 

 

66

 

 

 

 

 

 

19,405

 

Payment-in-kind

 

 

13,294

 

 

 

45

 

 

 

350

 

 

 

5,753

 

 

 

19,442

 

Net change in unrealized appreciation (depreciation)

 

 

2,740

 

 

 

5,565

 

 

 

83

 

 

 

(106

)

 

 

8,282

 

Net realized gains (losses)

 

 

(10,979

)

 

 

(10,505

)

 

 

 

 

 

(182

)

 

 

(21,666

)

Transfers into/out of Level 3 (3)

 

 

(18,059

)

 

 

 

 

 

 

 

 

 

 

 

(18,059

)

Fair value, end of period

 

$

5,442,166

 

 

$

2,112

 

 

$

6,520

 

 

$

55,995

 

 

$

5,506,793

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in unrealized appreciation (depreciation) from investments still held as of December 31, 2024

 

$

2,440

 

 

$

4,893

 

 

$

83

 

 

$

(106

)

 

$

7,310

 

 

 

(1)
Purchases may include investments received in corporate action and restructurings.
(2)
Sales may include investments received in corporate action and restructurings.
(3)
Transfer of portfolio investments within the three-level hierarchy is recorded during the period of such reclassification occurrence at the fair value as of the beginning of the respective period. Generally, reclassifications are primarily due to increase/decrease of price transparency.

The following tables present quantitative information about the significant unobservable inputs of the Company’s Level 3 financial instruments as of December 31, 2025 and December 31, 2024, respectively. The tables are not intended to be all-inclusive but instead capture the significant unobservable inputs relevant to the Company’s determination of fair value.

 

 

 

December 31, 2025

 

 

 

Fair

 

 

Valuation

 

Significant
Unobservable

 

Range (1)

 

 

Weighted

 

 

 

Value

 

 

Technique (2)

 

Input

 

Low

 

 

High

 

 

Average (3)

 

Investments in first lien debt

 

$

5,844,425

 

 

Yield Analysis

 

Discount Rate

 

 

7.48

%

 

 

39.21

%

 

 

9.25

%

 

 

50,145

 

 

Market Approach

 

EBITDA Multiple

 

6.25x

 

 

10.00x

 

 

8.31x

 

Investments in second lien debt

 

 

1,461

 

 

Yield Analysis

 

Discount Rate

 

 

12.27

%

 

 

12.75

%

 

 

12.38

%

 

 

14,675

 

 

Market Approach

 

EBITDA Multiple

 

7.75x

 

 

10.00x

 

 

7.86x

 

Other debt

 

 

6,667

 

 

Yield Analysis

 

Discount Rate

 

 

13.70

%

 

 

14.95

%

 

 

14.36

%

 

 

4,897

 

 

Market Approach

 

EBITDA Multiple

 

6.25x

 

 

7.75x

 

 

7.75x

 

Preferred equity

 

 

30,136

 

 

Income Approach

 

Discount Rate

 

 

12.09

%

 

 

15.66

%

 

 

13.55

%

 

 

12,439

 

 

Market Approach

 

EBITDA Multiple

 

7.75x

 

 

15.43x

 

 

12.99x

 

Common equity

 

 

6,693

 

 

Market Approach

 

Revenue Multiple

 

5.00x

 

 

22.25x

 

 

17.25x

 

 

 

5,747

 

 

Market Approach

 

EBITDA Multiple

 

1.20x

 

 

24.60x

 

 

11.61x

 

Total Investments

 

$

5,977,285

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
For an asset category that contains a single investment, the range is not included.
(2)
During the years ended December 31, 2025, two preferred equity positions with a combined fair value of $9.2 million transitioned from an income approach to a market approach valuation technique, four debt investments with a combined fair value of $45.2 million transitioned from a yield analysis to market approach valuation technique.
(3)
Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment.

 

 

 

December 31, 2024

 

 

 

Fair

 

 

Valuation

 

Significant
Unobservable

 

Range (1)

 

 

Weighted

 

 

 

Value

 

 

Technique (2)

 

Input

 

Low

 

 

High

 

 

Average (3)

 

Investments in first lien debt

 

$

5,439,606

 

 

Yield Analysis

 

Discount Rate

 

 

7.92

%

 

 

34.06

%

 

 

10.10

%

 

 

2,560

 

 

Market Approach

 

EBITDA Multiple

 

 

 

 

 

 

 

6.50x

 

Investments in second lien debt

 

 

2,112

 

 

Yield Analysis

 

Discount Rate

 

 

10.18

%

 

 

12.70

%

 

 

11.63

%

Other debt

 

 

6,225

 

 

Yield Analysis

 

Discount Rate

 

 

9.42

%

 

 

14.90

%

 

 

12.13

%

 

295

 

 

Market Approach

 

EBITDA Multiple

 

 

 

 

 

 

 

9.00x

 

Preferred equity

 

 

42,434

 

 

Income Approach

 

Discount Rate

 

 

12.19

%

 

 

17.50

%

 

 

15.13

%

 

 

2,462

 

 

Market Approach

 

EBITDA Multiple

 

 

 

 

 

 

 

8.50x

 

Common equity

 

 

5,043

 

 

Market Approach

 

Revenue Multiple

 

7.60x

 

 

12.70x

 

 

11.27x

 

 

 

6,056

 

 

Market Approach

 

EBITDA Multiple

 

3.90x

 

 

18.70x

 

 

13.77x

 

Total Investments

 

$

5,506,793

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)
For an asset category that contains a single investment, the range is not included.
(2)
During the year ended December 31, 2024, one unsecured debt position with a fair value of $3.07 million transitioned from an income approach to a yield analysis valuation technique.
(3)
Weighted average for an asset category consisting of multiple investments is calculated by weighting the significant unobservable input by the relative fair value of the investment. Weighted average for an asset category consisting of a single investment represents the significant unobservable input used in the fair value of the investment.

The significant unobservable input used in yield analysis is discount rate based on comparable market yields. Significant increases in discount rates in isolation would result in a significantly lower fair value measurement. The significant unobservable input used in the market approach is the comparable company multiple. The multiple is used to estimate the enterprise value of the underlying investment. An increase/decrease in the multiple would result in an increase/decrease, respectively, in the fair value. The significant unobservable inputs used in the income approach are the comparative yield or discount rate. The comparative yield and discount rate are used to discount the estimated future cash flows expected to be received from the underlying investment. An increase/decrease in the comparative yield or discount rate would result in a decrease/increase, respectively, in the fair value.

Financial instruments disclosed but not carried at fair value

The Company’s debt is presented at carrying value on the Consolidated Statements of Financial Condition. The fair value of the Company’s credit facilities and unsecured notes are estimated in accordance with the Company’s valuation policy. The carrying value and fair value of the Company’s debt were as follows:

 

December 31, 2025

 

 

December 31, 2024

 

 

Level

 

Carrying Value

 

 

Fair Value

 

 

Carrying Value

 

 

Fair Value

 

ING Facility

3

 

$

254,537

 

 

$

254,537

 

 

$

313,352

 

 

$

313,352

 

Wells Funding Facility

3

 

 

497,250

 

 

 

497,250

 

 

 

381,250

 

 

 

381,250

 

CBNA Funding Facility

3

 

 

225,000

 

 

 

225,000

 

 

 

93,750

 

 

 

93,750

 

JPM Funding Facility

3

 

 

744,073

 

 

 

744,073

 

 

 

614,073

 

 

 

614,073

 

Series A 2026 Notes(1)(6)

3

 

 

 

 

 

 

 

 

203,112

 

 

 

202,899

 

Series A 2028 Notes(1)(6)

3

 

 

145,151

 

 

 

146,080

 

 

 

144,986

 

 

 

143,487

 

Series B 2026 Notes(2)(6)

3

 

 

106,745

 

 

 

106,683

 

 

 

106,345

 

 

 

106,170

 

Series B 2028 Notes(2)(6)

3

 

 

127,227

 

 

 

128,152

 

 

 

126,945

 

 

 

125,503

 

Series C 2027 Notes(3)(6)

3

 

 

135,966

 

 

 

137,638

 

 

 

135,515

 

 

 

137,188

 

Series C 2029 Notes(3)(6)

3

 

 

162,425

 

 

 

167,204

 

 

 

162,094

 

 

 

164,336

 

Series D 2027 Notes(4)(6)

3

 

 

99,390

 

 

 

100,272

 

 

 

99,007

 

 

 

99,146

 

Series D 2029 Notes(4)(6)

3

 

 

198,349

 

 

 

200,709

 

 

 

197,890

 

 

 

196,159

 

2030 Notes(5)

3

 

 

294,837

 

 

 

294,837

 

 

 

293,686

 

 

 

293,686

 

2028 Notes(7)

3

 

 

294,582

 

 

 

294,080

 

 

 

 

 

 

 

Total

 

 

$

3,285,532

 

 

$

3,296,515

 

 

$

2,872,005

 

 

$

2,870,999

 

 

(1)
The carrying value of the Company’s Series A 2026 Notes and Series A 2028 Notes (each as defined below) was presented net of unamortized debt issuance costs of $0 and $849, respectively, as of December 31, 2025, and $888 and $1,014, respectively, as of December 31, 2024.
(2)
The carrying value of the Company’s Series B 2026 Notes and Series B 2028 Notes (each as defined below) was presented net of unamortized debt issuance costs of $255 and $773, respectively, as of December 31, 2025, and $655 and $1,055, respectively, as of December 31, 2024.
(3)
The carrying value of the Company’s Series C 2027 Notes and Series C 2029 Notes (each as defined below) was presented net of unamortized debt issuance costs of $534 and $1,075, respectively, as of December 31, 2025, and $985 and $1,406, respectively, as of December 31, 2024.
(4)
The carrying value of the Company’s Series D 2027 Notes and Series D 2029 Notes (each as defined below) was presented net of unamortized debt issuance costs of $610 and $1,651, respectively, as of December 31, 2025, and $993 and $2,110, respectively, as of December 31, 2024.
(5)
The carrying value of the Company’s 2030 Notes (as defined below) was presented net of unamortized debt issuance cost of $3,080, as of December 31, 2025, and $3,721 as of December 31, 2024. The carrying value of the Company’s 2030 Notes (as defined below) was presented net of unamortized original issue discount of $2,083, as of December 31, 2025, and $2,587 as of December 31, 2024.
(6)
Inclusive of change in fair market value of effective hedge.
(7)
The carrying value of the Company’s 2028 Notes (as defined below) was presented net of unamortized debt issuance costs and unamortized original issue discount of $3,488, and $1,930, respectively, as of December 31, 2025.

The carrying amounts of the Company’s assets and liabilities, other than investments at fair value and debt, approximate fair value. These financial instruments are categorized as Level 3 within the hierarchy.